Dexcom announces Team Novo Nordisk partnership. Dexcom stock costs EUR 76.20
AD HOC NEWS
Dexcom has announced a partnership with Team Novo Nordisk, making Dexcom the team's official continuous glucose monitoring partner. The announcement comes as Dexcom's stock traded at EUR 76.20 in weekend trading, a slight increase from its previous close. This partnership follows Dexcom's release of its 2026 State of Type 2 Report, which identified key challenges in diabetes care.
Read the full story
This is a short summary. The complete article is published by AD HOC NEWS.
Headline and summary aggregated from public news feeds. For information only — not financial advice.